Matinas BioPharma Holdings Inc (FRA:6LJ0)
€ 2.69 0 (0%) Market Cap: 3.23 Mil Enterprise Value: -7.02 Mil PE Ratio: 0 PB Ratio: 0.15 GF Score: 57/100

Matinas BioPharma Holdings Inc Annual Shareholders Meeting Transcript

Nov 02, 2020 / 02:00PM GMT
Release Date Price: €34.25 (-5.52%)
Jerome D. Jabbour
Matinas BioPharma Holdings, Inc. - Co-Founder, CEO, President & Director

Good morning. I am Jerry Jabbour, Chief Executive Officer of Matinas BioPharma Holdings, Inc. On behalf of the officers and the Board of Directors of Matinas, I would like to welcome you to our Annual Meeting of Stockholders. We are pleased to have each of you participating virtually.

First, we will dispose of the formal business of the Annual Meeting contained in the proxy materials previously mailed to all stockholders. At the conclusion of the formal portion of the meeting, we will make a short presentation regarding the company's business, and you will have the opportunity to submit questions at that time.

Before we begin the business portion of the meeting, I would like to recognize several individuals. Matinas' corporate officers present today are: Terry Ferguson, Chief Medical Officer; Keith Kucinski, Chief Financial Officer; and Terri Matkovits, Chief Development Officer. Also joining the call today is Mr. Ian Cooney, Director of Investor Relations and Corporate Development.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot